Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.

[1]  A. Papadia,et al.  Progestin suppressed inflammation and cell viability of tumor necrosis factor‐α‐stimulated endometriotic stromal cells , 2016, American journal of reproductive immunology.

[2]  M. Mueller,et al.  Dienogest mediates midkine suppression in endometriosis. , 2016, Human reproduction.

[3]  H. Nishi,et al.  Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis , 2016, The journal of obstetrics and gynaecology research.

[4]  F. Petraglia,et al.  Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis. , 2016, Journal of reproductive immunology.

[5]  B. McKinnon,et al.  Does dienogest influence the inflammatory response of endometriotic cells? A systematic review , 2016, Inflammation Research.

[6]  A. Yoshimura,et al.  Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  Y. Osuga,et al.  Simultaneous Detection and Evaluation of Four Subsets of CD4+ T Lymphocyte in Lesions and Peripheral Blood in Endometriosis , 2015, American journal of reproductive immunology.

[8]  C. Tayade,et al.  Pathophysiology and Immune Dysfunction in Endometriosis , 2015, BioMed research international.

[9]  G. Melis,et al.  Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[10]  Taisuke Mori,et al.  Dienogest reduces HSD17β1 expression and activity in endometriosis. , 2015, The Journal of endocrinology.

[11]  E. Baracat,et al.  Dienogest in the treatment of endometriosis: systematic review , 2015, Archives of Gynecology and Obstetrics.

[12]  S. Kyo,et al.  Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  Lifang Zhao,et al.  Transcriptional regulation of CCL20 expression. , 2014, Microbes and infection.

[14]  Adrian Y. S. Lee,et al.  CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis , 2014, Immunology and cell biology.

[15]  E. Sturlese,et al.  Chronic Pelvic Pain in Endometriosis: An Overview , 2013, Journal of clinical medicine research.

[16]  M. Ohmichi,et al.  Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis , 2012, Journal of Ovarian Research.

[17]  L. Giudice,et al.  Pathogenesis and pathophysiology of endometriosis. , 2012, Fertility and sterility.

[18]  S. Kaveri,et al.  Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. , 2012, The American journal of pathology.

[19]  C. Lange,et al.  Role of phosphorylation in progesterone receptor signaling and specificity , 2012, Molecular and Cellular Endocrinology.

[20]  D. Cochrane,et al.  The role of miRNAs in progesterone action , 2012, Molecular and Cellular Endocrinology.

[21]  N. Terakawa,et al.  The role of NF-kappaB in endometriosis. , 2012, Frontiers in bioscience.

[22]  P. Ghadjar,et al.  miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. , 2012, Cancer letters.

[23]  S. Kyo,et al.  Creation of immortalised epithelial cells from ovarian endometrioma , 2012, British Journal of Cancer.

[24]  Y. Shimizu,et al.  Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture. , 2012, Fertility and sterility.

[25]  T. Notsu,et al.  Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells. , 2011, Fertility and sterility.

[26]  H. Kanzaki,et al.  Progestins inhibit estradiol-induced vascular endothelial growth factor and stromal cell-derived factor 1 in human endometrial stromal cells. , 2011, Fertility and sterility.

[27]  D. Edwards,et al.  Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. , 2010, Molecular endocrinology.

[28]  P. L. McCormack Dienogest: a review of its use in the treatment of endometriosis. , 2010, Drugs.

[29]  Y. Taketani,et al.  Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. , 2010, Endocrinology.

[30]  T. Harada,et al.  Dienogest: a new therapeutic agent for the treatment of endometriosis. , 2010, Women's health.

[31]  Y. Taketani,et al.  Long‐term use of dienogest for the treatment of endometriosis , 2009, The journal of obstetrics and gynaecology research.

[32]  Y. Taketani,et al.  Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. , 2008, Fertility and sterility.

[33]  Y. Taketani,et al.  Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. , 2008, Endocrinology.

[34]  D. Corey,et al.  Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. , 2006, Molecular endocrinology.

[35]  N. Terakawa,et al.  Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. , 2005, Fertility and sterility.

[36]  H. Kanzaki,et al.  The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. , 2001, Molecular human reproduction.

[37]  B. O’Malley,et al.  Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. , 1993, Molecular endocrinology.

[38]  R. Kelly,et al.  Cytokine control in human endometrium. , 2001, Reproduction.